Comparison of polyspecific versus IgG specific ELISA in predominately cardiac patients with suspected heparin induced thrombocytopenia
Autor: | Sophie Samuel, Jennifer Cortes, Miguel A. Escobar, Phillip Weeks, Andy Nguyen, Mary F. McGuire |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
medicine.medical_specialty Specific test Heart Diseases Enzyme-Linked Immunosorbent Assay 030204 cardiovascular system & hematology Gastroenterology Sensitivity and Specificity 03 medical and health sciences 0302 clinical medicine Heparin-induced thrombocytopenia Internal medicine medicine Clinical endpoint Humans 030212 general & internal medicine Aged Hematology business.industry Heparin Incidence (epidemiology) Incidence Gold standard (test) Length of Stay Middle Aged medicine.disease Thrombocytopenia Direct thrombin inhibitor Immunoglobulin G Female Cardiology and Cardiovascular Medicine business medicine.drug |
Zdroj: | Journal of thrombosis and thrombolysis. 49(1) |
ISSN: | 1573-742X |
Popis: | A diagnosis of heparin induced thrombocytopenia (HIT) must often be made based on clinical and laboratory evidence. This was a quasi-experimental study of patients admitted from June 2016 to October 2017. The primary endpoint was the incidence of false positive results in polyspecific and IgG specific enzyme-linked immunosorbent assay (ELISA); then we compared the sensitivity and specificity of each assays in predominately cardiac patients with suspected HIT. A sensitivity/specificity analysis was conducted using serotonin release assay (SRA) as the ‘gold standard’. The secondary outcome measures included length of hospital stay. We identified a total of 155 patients who met the inclusion criteria. Confirmatory tests with SRA on both groups were completed; false positive result was higher in the polyspecific group when compared to the IgG group [60% vs. 5%]. The IgG specific ELISA test yielded a sensitivity of 100% and a specificity of 95% however, the polyspecific ELISA had a low yield for specificity of 24% but maintained 100% sensitivity. In the IgG specific group with HIT-, their median length of stay was halved compared to those who were HIT + ; hospital LOS in days, IQR [30 (27–81) vs. 15 (7–33) p = 0.023] and a shorter median LOS in the ICU, IQR [24 (5–47) vs. 6 (2–14); p = 0.079]. Hospital or ICU LOS was the same in both (HIT+ and HIT−) groups managed with polyspecific ELISA. The IgG specific test had few false positive results and a high sensitivity score. Ensuring appropriate testing can bring a substantial decrease in drug expenditure, reduced length of stay and prevent unnecessary anticoagulation. |
Databáze: | OpenAIRE |
Externí odkaz: |